How many high production chemicals are rodent carcinogens? Why should we care? What do we need to do about it?

• Published in: Mutation Research-Reviews in Mutation Research Vol. 543; no. 3; pp. 201 - 215
• Main Author: Johnson, F.M.
• Format: Book Review Journal Article
• Language: English
• Published: Lausanne Elsevier B.V 01.06.2003; Amsterdam Elsevier Science; New York, NY
• Subjects: Air Pollutants; Animals; Biological and medical sciences; Cancer; Carcinogenicity Tests - methods; Carcinogens; Carcinogens - toxicity; Chemical Industry; Chemical mutagenesis; Databases, Factual; Drug Administration Routes; Environmental Exposure; Environmental Protection Agency; EPA; High production chemicals; HPV; Medical sciences; Mutagenicity Tests; National Toxicology Program; NTP; Rodent bioassay; Rodentia; Toxicology; Carcinogens; Rodent bioassay; EPA; National Toxicology Program; High production chemicals; Environmental Protection Agency; NTP; Cancer; HPV
• ISSN: 1383-5742; 0027-5107; 1388-2139
• DOI: 10.1016/S1383-5742(02)00091-1

High production volume (HPV) chemicals are produced in or imported to the US in amounts greater than 1 million pounds per chemical per year. The EPA has identified thousands of HPVs. Due to their abundance, such chemicals bring a substantial risk for human exposure, and as a result some level of adverse consequences to health are to be expected. In order to examine the potential for cancer risk associated with HPVs, this paper examines HPVs that have been tested in the National Toxicology Program’s rodent cancer bioassay. The chemicals tested in the bioassay represent a small sample of the universe of environmental chemicals to which people are exposed. Unexpectedly, 60% of the 128 HPVs evaluated in the bioassay proved to be rodent carcinogens. This value compares to a predicted prevalence of only 16.5% carcinogens in a previous study. The previous study concluded that HPVs were less likely to be toxic by a variety of other test criteria as well. However, the approach involved identifying putative carcinogens using quantitative chemical structure-activity relationships (QSAR) in contrast to the direct tabulation of bioassay test results performed here. Detailed examination of bioassay results reveals that test outcomes depend heavily on route of administration as well as on dose level, sex, strain, and species used. Since most of these factors have little or no apparent relationship to chemical structure, results of this study suggest that QSAR, as well as virtually all other alternative methods, may not generally provide accurate predictions of carcinogenic potential. As we wait for efficient and effective methods for predicting carcinogens to be developed, people continue to be exposed to environmental carcinogens. Progress on regulating environmental carcinogens as well as on developing more effective test methods has been minimal since “war on cancer” began approximately 30 years ago. The present study questions whether the current strategy for dealing with environmental carcinogens will ever be successful. Close examination of rodent cancer test results seems to suggest that almost all chemicals may have carcinogenic potential in some genotypes under some exposure circumstances. If this hypothesis is correct, it would explain the general lack of progress in developing methods to differentiate carcinogens from noncarcinogens. A completely new strategy for dealing with cancer caused by exposures to environmental chemicals seems to be needed.